Insider buying last 90 days
$1.20Min 2 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 27 | Gundlach Andrew director | Purchase | $605K |
| Aug 27 | Gundlach Andrew director | Purchase | $599K |
From Form 4 filings, dated to when each was filed.
Close on Sep 18, 2026. Page updated Sep 19, 9:18 pm ET.
Welltower closes at $228.87, down 1.5% on the day, sitting between its 50-day average of $237.56 and 200-day average of $212.35. The GekkoIndex reads 68.2, placing the stock in the Accumulation zone, up 8.7 over the last five readings. Gekko Fair Value stands at $231.77, putting the current price 1.3% below that level. Over the past year the stock has returned 37.9%, with three-month and six-month returns of 10.8% and 11.1% respectively, against a 52-week range of $163.75 to $255.20.
This week's coverage centers on analyst and institutional activity alongside continued senior housing momentum. Jefferies upgraded the stock to Buy and raised its price target to $275 from $261, citing demographics and limited new supply in senior housing. Nykredit A/S disclosed a purchase of 324,783 shares worth approximately $73.7 million, while Bank of America Corp DE reported a new position of over 19 million shares valued at approximately $4.4 billion, equal to about 2.71% of the company. Separately, Welltower completed a $40.6 million acquisition of Arcadia At Limerick Pointe from Vantage Point Retirement Living and Signature Realty Advisors, and reports point to continued double-digit NOI growth in the senior housing portfolio.
The next earnings date falls on 26 October 2026, 36 days out and beyond a typical 20-trading-day hold; the prior report on 27 July showed EPS of $1.60 against an estimate of $1.55, with a subsequent reaction of -3.4%. Insider activity over the last 90 days includes 2 open-market purchases totaling $1,203,825. Seasonality over the next 20 trading days has averaged -1.4% across 5 years, with gains in 3 of those years, a pattern worth noting alongside 14 of 16 covering analysts rating the stock Buy and a consensus target of $262.23.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Welltower scores 3 supportive, 3 mixed and 0 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive3 mixed0 headwinds
Averages disagree
Close $228.87 sits between the 50-day ($237.56) and 200-day ($212.35) averages, or the averages disagree.
See the chart68.2, Accumulation
Reading 68.2 is in the Accumulation zone.
See the GekkoIndex1.3% below
Price is within 5% of Gekko Fair Value (1.3% below).
See fair valueLeans bullish
Last 90 days: 2 open-market insider purchases.
See smart moneyReports in 36 days
Next report Oct 26, 2026, 36 days away — outside a typical 20-trading-day hold.
See earnings−1.4% on average
From this point in the calendar, the next 20 trading days averaged −1.4% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Welltower closed at $228.87 on Sep 18, 2026, +37.9% over the past year, inside a 52-week range of $163.75 to $255.20.
Use the left and right arrow keys to read daily values.
Put WELL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Welltower funds and owns the buildings where healthcare and elder care actually happen, rather than delivering that care itself. It teams up with established operators who run senior living communities, rehabilitation and recovery facilities, and hospital-linked services, supplying the real estate those groups depend on.
As a real estate investment trust, Welltower makes money by acquiring and leasing out properties used for senior living, recovery care, and outpatient medical treatment. Its tenants are the operating companies that manage day-to-day care on site, and its buildings are concentrated in growing regions spread across America, Canada, and Britain.
The company is headquartered in Toledo, Ohio, and belongs to the S&P 500 index. Its stock is listed on the NYSE under the ticker WELL.
Welltower’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 68.2, in the Accumulation zone, up 8.7 points over five sessions.
Up 8.7 points over five sessions, from the Neutral zone.
Reading for Sep 18, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 11 | +2.3% | +9.0% | ||
| Accumulation (current zone) | 99 | +1.5% | +6.5% | ||
| Neutral | 454 | +0.7% | +3.1% | ||
| Distribution | 50 | +0.2% | −1.3% | ||
| Selling | 1 | Too few readings yet | |||
Average WELL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Welltower trades 1.3% below Gekko Fair Value of $231.77, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Welltower shares are worth, recalculated every trading day.
$231.77
Gekko Fair Value, Sep 19, 2026
1.3% below fair value · About fair value
Insiders filed 2 open-market purchases in Welltower worth $1.20M, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$1.20Min 2 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 27 | Gundlach Andrew director | Purchase | $605K |
| Aug 27 | Gundlach Andrew director | Purchase | $599K |
From Form 4 filings, dated to when each was filed.
No trades in WELL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Welltower has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold WELL.
Welltower reports on Oct 26, 2026 (36 days away), and beat the EPS estimate in 6 of its last 8 reports.
Oct 26, 2026
36 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 27, 2026 | $1.60 est $1.55 | $3.54B est $3.40B | −3.4% |
| Apr 28, 2026 | $0.55 est $0.50 | $3.35B est $3.12B | +1.0% |
| Feb 10, 2026 | $0.55 est $0.59 | $3.18B est $2.86B | +5.4% |
| Oct 27, 2025 | $1.34 est $1.30 | $2.69B est $2.96B | +1.0% |
| Jul 28, 2025 | $1.28 est $1.22 | $2.52B est $2.72B | +2.7% |
| Apr 28, 2025 | $1.20 est $1.15 | $2.39B est $2.52B | +3.1% |
| Feb 11, 2025 | $0.34 est $0.41 | $2.22B est $2.19B | +2.4% |
| Oct 28, 2024 | $0.73 est $0.38 | $2.01B est $2.07B | +5.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Welltower is $262.23, +14.6% from the last close, from 16 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 16 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 15 | Jefferies | $275 | +20.2% |
| Sep 3 | J.P. Morgan | $260 | +13.6% |
| Sep 2 | Morgan Stanley | $251 | +9.7% |
| Sep 2 | Scotiabank | $251 | +9.7% |
| Sep 1 | Wells Fargo | $266 | +16.2% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 19, Welltower averaged −1.4% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.5% | 2 of 5 |
| Next 10 trading days | −2.1% | 1 of 5 |
| Next 15 trading days | −5.0% | 1 of 5 |
| Next 20 trading days | −1.4% | 3 of 5 |
| Next 30 trading days | −0.1% | 2 of 5 |
For scale, WELL’s typical 20-trading-day move in either direction is about 4.4%.
Welltower’s market cap is $164.9B, with a P/E ratio of 104.2 and revenue of $12.76B over the last twelve months.
Coverage of Welltower this week reads positive: 8 positive, 1 neutral and 1 negative headlines.
Welltower’s market cap is $164.9B at the Sep 18, 2026 close of $228.87, with 720.6M shares outstanding. The shares trade on a P/E ratio of 104.2.
The consensus analyst 12-month price target for Welltower is $262.23, +14.6% from the last close. Of the 16 firms that rated the stock in the last 90 days, 14 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Welltower is about fair value: the Sep 18, 2026 close of $228.87 is 1.3% below Gekko Fair Value of $231.77. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Welltower is expected to report on Oct 26, 2026 (36 days away). Analysts expect earnings of $0.64 per share on revenue of $3.63B. Welltower beat the earnings estimate in 6 of its last 8 reports, moving 3.1% on average across the report.
Welltower’s 52-week high is $255.20 and its 52-week low is $163.75; it closed at $228.87 on Sep 18, 2026, +37.9% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (gekkoindex, smart money and earnings risk), 3 as mixed (trend, fair value and seasonality). The checklist is a description of current data, not a recommendation.
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.